g.tamm
TL2 Moderator · Palermo
Contributes reviews on supplier material. Based in Palermo.
Joined 19 April 2025 · last posted 11h
83Posts here
0Topics
2Solutions
304Likes received
430Likes given
19Badges
133Days visited
1.2kPosts read
Recent activity
Full stream-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #82 · Outcomes › Progress reports · 27 Jul 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #45 · Clinical › Prescriber conversations · 24 Jul 2026 · 0 likes On post #41 — agreed on the reasoning, with one qualification. How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence…
-
Deletion sequences: expected mass shifts by residue — the long version Replied, post #21 · Analytics › Impurities & related substances · 23 Jul 2026 · 0 likes Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be…
-
Request: a per-category review queue Replied, post #122 · Meta › Feature requests · 22 Jul 2026 · 8 likes Requests for platform and documentation features, with the reasoning that justifies them. If you think the site would be better with a feature, suggest it with enough…
-
Hair shedding at month three: mechanism and time course — the long version Replied, post #49 · Practice › Side effects · 18 Jul 2026 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Which categories are strict and which are relaxed, honestly Replied, post #25 · Start Here › Welcome · 18 Jul 2026 · 0 likes Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #101 · Compounds › Semaglutide · 12 Jul 2026 · 0 likes Worth separating two things that post #97 runs together. The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #33 · Pharmacology › Receptor biology · 2 Jul 2026 · 5 likes GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin secretion), on neurons (appetite and gastric motility), and on myocardium…
-
How shortages have affected compounding permissions Replied, post #5 · Access › Shortages · 29 Jun 2026 · 21 likes Worth separating two things that the opening post runs together. Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when…
-
Personal or family history of medullary thyroid carcinoma Replied, post #14 · Safety › Contraindications · 25 Jun 2026 · 0 likes I read post #12 twice before replying, because I had assumed the opposite. Severe hepatic impairment: less is known than for kidney disease. Extreme caution or…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #47 · Evidence › Journal club · 21 Jun 2026 · 2 likes post #46 answers the question as asked. The question underneath it is different. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #86 · Sourcing › Vendor reports · 18 Jun 2026 · 10 likes On post #82 — agreed on the reasoning, with one qualification. Disputed records: when a result disagreed and was not explained, the record says disputed and stays that…